Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns
19/05/2023 17:01
May 19 (Reuters) - Epigenomics AG ECX1k.DE :
* EQS-ADHOC: EPIGENOMICS AG: CHANGES IN THE MANAGEMENT
* EPIGENOMICS - MEMBER OF EXECUTIVE BOARD, PRESIDENT, AND
CHIEF
SCIENTIFIC OFFICER OF CO, ANDREW LUKOWIAK, IS RESIGNING
EFFECTIVE MAY 31, 2023
Source text for Eikon: ID:nEQ6YDwP1a
Further company coverage: ECX1k.DE
((reuters.briefs@thomsonreuters.com;))
Recent news on Epigenomics AG
See all newsU.S. FDA advisers back approval for Guardant's blood-based cancer test (updated)
U.S. FDA advisers back approval for Guardant's cancer test
Brief: Epigenomics Says Closing Of Agreement On The Acquisition Of Almost All Assets And Adjustment Of Guidance For 2023
Brief: Epigenomics AG Says It Entered Into Agreement On The Acquisition Of Almost All Assets With New Day Diagnostics LLC
Brief: Epigenomics Says Chief Scientific Officer Andrew Lukowiak Resigns